Compounded tirzepatide products should be avoided unless there is an FDA-recognized shortage and the compounding pharmacy is appropriately licensed
JAMA Cardiol 2021;6:148-58.ArticlePubMed 46
Equally, heterogeneity in patient groups, the absence of uniformity in case definitions, and differences in reliability and precision could have resulted in there being no correlation between the viral load and serological data (61, 99, 103, 109)
As with lecanemab and donanemab, individuals should talk with their doctors to develop a treatment plan that is right for them, including weighing the benefits and risks of all therapies
Discard the vial and start over with the right solvent do not inject a cloudy solution
JAMA Netw Open 2024;7:e2423385.ArticlePubMedPMC 74